Results

Total Results: 171 records

Showing results for "sickle cell disease".

  1. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
    January 01, 2011 - CHIPRA 133: Section 2 Technical Specifications Section II: Detailed Measure Specifications Provide sufficient detail to describe how a measure would be calculated from the recommended data sour…
  2. www.ahrq.gov/hai/pfp/haccost2017-appendix.html
    November 01, 2017 - Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions Appendixes Previous Page   Table of Contents Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions Discussion Resu…
  3. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-figure-1-tables-1-5.pdf
    January 01, 2011 - pulmonary communication skills, and key educational messages complications such as tuberculosis, sicklecell disease, cystic fibrosis) (N=870) 2 Low-income children in the treatment group tended to have
  4. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-reimagining-healthcare-teams.pdf
    July 07, 2023 - Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sicklecell disease.
  5. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
    April 30, 2025 - Purpose: Evaluate automated detection methods for adverse drug events (ADEs) in pediatric patients with sicklecell anemia, cystic fibrosis, and cancer in the ambulatory setting. … Key Findings/Impact: Researchers found a high rate of ADEs in pediatric patients with sickle cell disease
  6. www.ahrq.gov/sites/default/files/2024-10/gorelick-report.pdf
    January 01, 2024 - vomiting seizures/seizure disorder excludes: febrile seizures developmental delay cystic fibrosis sicklecell disease failure to thrive diabetes mellitus spinal cord injuries hemophilia or other bleeding
  7. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-131-fullreport.pdf
    April 05, 2017 - Outpatient follow-up and rehospitalizations for sickle cell disease patients.
  8. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
    January 01, 2020 - Identifying sickle cell disease cases using administrative claims.
  9. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/opioids-1.pdf
    March 01, 2020 - ED, with 1 visit primarily driven by opioid- seeking behavior; adults age 18–67, cancer and sicklecell disease excluded Control group (crossover) One ED in Indianapolis, IN, serving 102,000
  10. www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
    November 01, 2017 - Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions FINAL REPORT Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions PREPARED FOR: Agency for Healthcare Resear…
  11. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
    November 01, 2017 - Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions FINAL REPORT Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions PREPARED FOR: Agency for Healthcare Resear…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: